- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jiangsu Nhwa Pharmaceutical Co Ltd (002262)
Jiangsu Nhwa Pharmaceutical Co Ltd stock price live, this page displays SZ 002262 stock exchange data. View the 002262 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jiangsu Nhwa Pharmaceutical Co Ltd real time stock price chart below.
What Is the Jiangsu Nhwa Pharmaceutical Co Ltd Stock Price Today?
The Jiangsu Nhwa Pharmaceutical Co Ltd stock price today is 21.91.
What Is the Stock Symbol for Jiangsu Nhwa Pharmaceutical Co Ltd?
The stock symbol for Jiangsu Nhwa Pharmaceutical Co Ltd is "002262."
What Stock Exchange Does Jiangsu Nhwa Pharmaceutical Co Ltd Trade On?
Jiangsu Nhwa Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Jiangsu Nhwa Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Nhwa Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002262 quote. (ISIN: CNE100000CG8)
What Is the Jiangsu Nhwa Pharmaceutical Co Ltd Stock Price Today?
The Jiangsu Nhwa Pharmaceutical Co Ltd stock price today is 21.91.
What Is the Stock Symbol for Jiangsu Nhwa Pharmaceutical Co Ltd?
The stock symbol for Jiangsu Nhwa Pharmaceutical Co Ltd is "002262."
What Stock Exchange Does Jiangsu Nhwa Pharmaceutical Co Ltd Trade On?
Jiangsu Nhwa Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Jiangsu Nhwa Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Nhwa Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 002262 quote. (ISIN: CNE100000CG8)
Shenzhen
Currency in CNY
21.91
-0.32(-1.44%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.86
22.37
52 wk Range
17.96
29.30
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
21.8622.37
52 wk Range
17.9629.30
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.83%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
002262 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
26.70
Upside
+21.86%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 3 consecutive years
Nhwa Pharma A Earnings Inline, Revenue misses In Q3- Investing.com
- Nhwa Pharma A Earnings Inline, Revenue misses In Q3
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 26.70
(+21.86% Upside)
Earnings
Latest Release
Apr 18, 2026
EPS / Forecast
0.31 / 0.47
Revenue / Forecast
1.61B / 1.73B
Compare 002262 to Peers and Sector
Metrics to compare | 002262 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002262PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.0x | 19.7x | −0.4x | |
PEG Ratio | −2.23 | 0.89 | 0.00 | |
Price/Book | 2.7x | 2.3x | 2.6x | |
Price / LTM Sales | 3.8x | 3.3x | 3.0x | |
Upside (Analyst Target) | 22.8% | 24.6% | 54.3% | |
Fair Value Upside | Unlock | 16.4% | 8.4% | Unlock |
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research, development, production, and sale of central nervous system products in China. The company offers APIs, solid preparation, water injection, and freeze-dried powder formulations for depression, anxiety disorders, insomnia, severe mental disorders, and neurodegenerative diseases. Its products include sufentanil citrate injection, oxaliplatin fumarate injection, alfentanil hydrochloride injection, oxycodone hydrochloride injection, olanzapine tablets, midazolam hydrochloride oral solution, clonazepam injection, lacosamide injection, micuronium injection, pregabalin capsules, vortioxetine hydrobromide tablets, tapentadone hydrochloride tablets, and oxycodone hydrochloride extended-release tablets. The company was founded in 1978 and is headquartered in Xuzhou, China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Nhwa Pharma A (002262) Stock Price Today?
The Nhwa Pharma A stock price today is 21.91 CNY.
What Stock Exchange Does Nhwa Pharma A Trade On?
Nhwa Pharma A is listed and trades on the Shenzhen Stock Exchange.
What Is the Stock Symbol for Nhwa Pharma A?
The stock symbol for Nhwa Pharma A is "002262."
Does Nhwa Pharma A Pay Dividends? What’s The Current Dividend Yield?
The Nhwa Pharma A dividend yield is 1.83%.
What Is the Nhwa Pharma A Market Cap?
As of today, Nhwa Pharma A market cap is 22.26B CNY.
What Is Nhwa Pharma A's Earnings Per Share (TTM)?
The Nhwa Pharma A EPS (TTM) is 1.06.
When Is the Next Nhwa Pharma A Earnings Date?
Nhwa Pharma A will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is 002262 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Nhwa Pharma A Stock Split?
Nhwa Pharma A has split 7 times.
How Many Employees Does Nhwa Pharma A Have?
Nhwa Pharma A has 6003 employees.
What is the current trading status of Nhwa Pharma A (002262)?
As of Aug 04, 2026, Nhwa Pharma A (002262) is trading at a price of 21.91 CNY, with a previous close of 22.23 CNY. The stock has fluctuated within a day range of 21.86 CNY to 22.37 CNY, while its 52-week range spans from 17.96 CNY to 29.30 CNY.
What Is Nhwa Pharma A (002262) Price Target According to Analysts?
The average 12-month price target for Nhwa Pharma A is 26.70 CNY, with a high estimate of 30 CNY and a low estimate of 23 CNY. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +21.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.